Amarin Corp Plc (AMRN)

[jessellivermore]

Irish....

The BB issue is a non starter..Sales were proximal to the label issues and not the patent litigation.. Though enormous by our scale..a drop in the bucket for the BBs. So what and where are the customers..

A high probability we win the generic case. (The major overhang right now)...With that in mind we can look at the potential customers..I think Amarin management understands this issue more than most of the posters on this site..We have the majors USA, Europe. The minors Canada, the Middle East...I am not including China because it is a wild card...35 mil USA..45Mil Europe...80 mil...These are just for the CVD indications.

Fact is if you understand Vascepa..It is basically "good for you" and can be viewed as an anti aging remedy and to reduce the likelihood of developing most degenerative diseases.. This might be talking "down the road"..but it might not be as far down the road as a lot of you think. Its not so much about longevity...its about the ability to stay "younger"..longer..Not just being a frail, diseased, old person...But someone who functions more like a younger person...

That theoretically means everyone would be better off if they were on V..at a certain age.

I understand this sounds mind blowing...but it is true..Vascepa has very few side effects and that is the other side of the penny..V might be helpful for anyone over the age of 35...Fact is V has been mainly looked at as a cure...When the real value is in its ability to prevent..

So an argument can be made that everyone without a specific intolerance to V...Becomes a potential customer for V once they reach an age where the body begins the degenerative passage culminating in that long sleep.

Not merely for the reason of putting more miles on the jalopy till the "nines roll over"...But to keep things running smoother..

What's Amarn worth..Vascepa is worth more..much more than most of us can fathom.

JMO..":>) JL